Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
COMPASS Pathways plc (CMPS) is a leading medical care facilities business based in the US. It opened the day at $16.10 after a previous close of $16.30. During the day the price has varied from a low of $15.51 to a high of $16.80. The latest price was $15.77 (25 minute delay). COMPASS Pathways is listed on the NASDAQ and employs 61 staff. All prices are listed in US Dollars.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Open | $16.10 |
|---|---|
| High | $16.80 |
| Low | $15.51 |
| Close | $15.77 |
| Previous close | $16.30 |
| Change | $-0.53 |
| Change % | -3.2515% |
| Volume | 407,269 |
| 52-week range | $14.04 - $58.62 |
|---|---|
| 50-day moving average | $25.55 |
| 200-day moving average | $32.56 |
| Wall St. target price | $79.70 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-1.68 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $15.77 from 2022-01-26
| 1 week (2022-01-21) | 15.77 |
|---|---|
| 1 month (2021-12-28) | -27.69% |
| 3 months (2021-10-28) | -60.61% |
| 6 months (2021-07-28) | -55.96% |
| 1 year (2021-01-28) | -64.13% |
|---|---|
| 2 years (2020-01-24) | N/A |
| 3 years (2019-01-24) | N/A |
| 5 years (2017-01-24) | N/A |
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -14.02% |
| Return on equity TTM | -25.53% |
| Profit margin | 0% |
| Book value | $7.32 |
| Market capitalisation | $658.1 million |
TTM: trailing 12 months
We're not expecting COMPASS Pathways to pay a dividend over the next 12 months.
COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin formulation that is in Phase IIb clinical trial to treat patients with treatment-resistant depression. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is based in Cheshire, the United Kingdom. .
Lido’s liquid staking allows investors holding LUNA and less than 32 ETH to reap the rewards of DeFi staking.
Downturns often let you buy fundamentally strong stocks at bargain prices, but mind the fundamentals and consider these 3 rules.
The crypto market wiped out $1.5 trillion in value in just three months.
Bitcoin breached the $40,000 price level and may plummet lower as Russia signals a potential ban.
Cardano’s first metaverse project is available to investors now — if you can find a piece of digital land on sale. Plots sold fast despite the project’s early stage limitations.
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Read our expert analysis on Vigorus and how the token will perform in the future.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
